Key facts
- It has raised $9.1M across 3 recorded rounds; the latest was Early Stage VC ($7.2M) in Apr 2017.
- Notable investors include Alumni Ventures, US National Science Foundation, Impact Assets, MedTech Innovator, Village Capital — 18 tracked in total.
- Innoblative Designs has filed 4 Form Ds with the SEC since 2016, most recently Oct 2019 ($7.2M sold to 37 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Innoblative Designs
Funding rounds
3 roundsAbout Innoblative Designs
Developer of an electrosurgical radiofrequency ablation device designed to eliminate residual cancer cells during breast-conserving surgery. The company offers intraoperative radiofrequency ablation technology, enabling breast cancer surgeons to reduce repeat surgeries and limit the need for additional treatments.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2013
- Employees
- 6
- Website
- innoblative.com/
- Ownership
- Privately Held (backing)
Innoblative Designs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Innoblative Designs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Innoblative Designs in its N-PORT filings yet. We sweep new filings monthly.